Oulu University Hospital
Oulu, 90220, Finland
NCT Number: NCT02283229
Prospective randomized clinical interventional trial after birth in maternity ward, and follow up to 8-9 years of age.
Hypothesis: Preventive handling and caring advices to parents of newborns decrease craniofacial asymmetries (deformational plagiocephaly and torticollis). The minimum sample size of the study was calculated at 86 (43 in each arm) using a 5% significance level, a power of 80% and a fall in the prevalence of DP from 31% to 8%. Craniofacial asymmetries and appearances of occlusal defects are followed up to 9 years. 50 preterm infants can participate without intervention.
Interested in participating?
Request Info1 day–6 day
All sexes
Interventional
Not applicable
Oulu, 90220, Finland
The amount of craniofacial abnormal molding after birth in newborns and the frequency of plagiocephaly in infancy or later consequences of those in childhood are not known in finnish population. Head malposition and deformational plagiocephaly, however, have been linked to delayed development in early life and even much later to orthognathic problems demanding surgery in adulthood.
In this study parents with healthy newborns are randomized to have normal discharge home or discharged with extra advice information for caregivers; to charge both sided feeding and handling habits; to change regularly sleeping and lying positions; to have early tummy times.
Anthropometric measurements of the infants; tilting degrees of the head and rotations of the neck (range of movement =ROM) are taken at discharge home and at the age of 3 and 6 months, and 1, 3, 5-6 and 8-9 years. Two-dimensional digital photographs (upto the age of 6 months) and three-dimensional imaging (from the age of 3 months) are taken to measurements of the head shape (Cephalic index=CI and (approximate) Oblique Cranial Length Ratio= (a)OCLR measured using a semiautomated, computer-based method). The development quotient by Griffiths scales are assessed at the age of 3 and 6 months. Dental occlusal defect evaluation are started at the age of 3 ys.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Advices to prevent head molding
Normal handling
Time frame: 3 months
The number of children in groups with plagiocephaly (CI, OCLR =/> 104%)
Time frame: 3 months
The number of children in groups with plagiocephaly as mild; aOCLR 104-107%; moderate 107-111%; severe =/>111 %
Time frame: From 3 to 6 months
The number of children in groups with plagiocephaly as mild; aOCLR 104-107%; moderate 107-111%; severe =/>111 %
Time frame: 6 years
The number of children in groups with occlusal defects
Time frame: from 6 years to 10 years
The number of children with occlusal defects
Time frame: from 6 years to 10 years
The number of children with facial asymmetry
Time frame: from 10 years to 15 years
The number of children with occlusal defects
Time frame: from 10 years to 15 years
The number of children with facial asymmetry
Time frame: 3 months
Difference in Development quotients by Griffiths scales in groups
Time frame: From 3 months to 6 months
Difference in Development quotients by Griffiths scales in groups
University of Oulu
Other
Newborn Head Molding and Later Asymmetries in Follow up (3D Head Shape Modelling)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06425172
Bone Diseases, Bone Diseases, Developmental
Dallas, Texas, United States
View Trial DetailsNCT07356401
Behavior, Congenital Abnormalities
Ankara, Keçiören, Turkey (Türkiye)
View Trial DetailsNCT05848895
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
San Diego, California, United States
View Trial DetailsNCT06173102
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Montreal, Quebec, Canada
View Trial Details